Midway through a M.D./Ph.D program at UCLA, Alice Zhang made a discovery that she felt could reverberate far beyond the halls of academia. So she shifted directions, leaving her Ph.D program to found Verge Genomics, a biomedical firm that aims to unite genetic research and artificial intelligence in service of drug discovery. She describes how AI can revolutionize the drug discovery process, and reframes risk-taking as a simple series of optimistic next steps.
Related
Luke Sykora,
Stanford University
Starting Up in a Downturn
An Entrepreneurial Thought Leaders mini-guide for aspiring founders facing a troubled economy.
Josh Makower, MD,
Stanford Byers Center for Biodesign
The Biodesign Innovation Process [Entire Talk]
Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.
Josh Makower, MD,
Stanford Byers Center for Biodesign
The Biodesign Innovation Process [Entire Talk]
Innovation isn’t random – it’s a process that can be learned, improved, and effectively deployed to solve specific problems.
John Felts,
Cruz Foam
Engineering Green Materials [Entire Talk]
To scale a technology, engineers need to think beyond the technology itself.
John Felts,
Cruz Foam
Engineering Green Materials [Entire Talk]
To scale a technology, engineers need to think beyond the technology itself.
